Annovis Bio Total Assets Over Time
| ANVS Stock | USD 6.54 0.02 0.30% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Annovis Bio Performance and Annovis Bio Correlation. Annovis |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.22) | Return On Assets (1.55) | Return On Equity (5.97) |
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare Annovis Bio and related stocks such as Bright Minds Biosciences, HP Inc, and Intel Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRUG | 164 K | 164 K | 164 K | 164 K | 164 K | 164 K | 164 K | 164 K | 164 K | 880.2 K | 20 M | 12.1 M | 6.9 M | 7.9 M | 8.8 M |
| HPQ | 5.7 B | 108.8 B | 105.7 B | 103.2 B | 106.9 B | 29 B | 32.9 B | 34.6 B | 33.5 B | 34.7 B | 38.6 B | 38.6 B | 37 B | 42.6 B | 56 B |
| INTC | 2.2 B | 71.1 B | 84.4 B | 92.4 B | 92 B | 103.1 B | 113.3 B | 123.2 B | 128 B | 136.5 B | 153.1 B | 168.4 B | 182.1 B | 191.6 B | 201.2 B |
| CVX | 34.7 B | 209.5 B | 233 B | 253.8 B | 266 B | 264.5 B | 260.1 B | 253.8 B | 253.9 B | 237.4 B | 239.8 B | 239.5 B | 257.7 B | 261.6 B | 171.8 B |
| KO | 6.9 B | 80 B | 86.2 B | 90.1 B | 92 B | 90 B | 87.3 B | 87.9 B | 83.2 B | 86.4 B | 87.3 B | 94.4 B | 92.8 B | 97.7 B | 102.6 B |
| TRV | 6.9 B | 104.6 B | 104.9 B | 103.8 B | 103.1 B | 100.2 B | 100.2 B | 103.5 B | 104.2 B | 110.1 B | 116.8 B | 120.5 B | 115.7 B | 126 B | 73.6 B |
| JNJ | 5.1 B | 113.6 B | 121.3 B | 132.7 B | 131.1 B | 133.4 B | 141.2 B | 157.3 B | 153 B | 157.7 B | 174.9 B | 182 B | 187.4 B | 167.6 B | 175.9 B |
| JPM | 71.5 B | 2.3 T | 2.4 T | 2.4 T | 2.6 T | 2.4 T | 2.5 T | 2.5 T | 2.6 T | 2.7 T | 3.4 T | 3.7 T | 3.7 T | 3.9 T | 4.1 T |
| MSFT | 170.7 M | 121.3 B | 142.4 B | 172.4 B | 176.2 B | 193.7 B | 241.1 B | 258.8 B | 286.6 B | 301.3 B | 333.8 B | 364.8 B | 412 B | 512.2 B | 537.8 B |
Annovis Bio and related stocks such as Bright Minds Biosciences, HP Inc, and Intel Total Assets description
Total assets refers to the total amount of Annovis Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Annovis Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Annovis Bio | ANVS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Pennsylvania; U.S.A |
| Exchange | New York Stock Exchange |
USD 6.54
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.